A qualitative process evaluation of a clinical trial on bedside model-informed precision dosing of vancomycin in

Lise-Marie Kinnaer1, Anca Amza2, Pieter De Cock3,4,5

  • 1Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Abstract

Insights

Model-Informed Precision Dosing (MIPD) software improved clinician confidence in vancomycin therapy for critically ill children. Streamlining workflows and integrating MIPD into electronic health records are key for sustained adoption in pediatric critical care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacometrics and Pharmacokinetics
  • Health Services Research

Background:

  • Model-Informed Precision Dosing (MIPD) is vital for optimizing vancomycin therapy in critically ill patients.
  • Process evaluations of MIPD randomized controlled trials (RCTs) are scarce, especially in pediatric intensive care settings.
  • Understanding the 'how' and 'why' of MIPD interventions is crucial for successful implementation.

Purpose of the Study:

  • To explore healthcare professionals' (HCPs) experiences using MIPD software for vancomycin during a pediatric RCT.
  • To identify contextual factors influencing the adoption and sustained use of MIPD in critically ill children.
  • To gather insights for improving MIPD implementation strategies in pediatric critical care.

Main Methods:

  • A qualitative descriptive exploratory study was conducted post-BENEFICIAL-RCT in 8 Belgian hospitals.
  • Semi-structured interviews and focus groups were held with physicians, pharmacists, biologists, and nurses.
  • Thematic analysis was used to analyze data collected between January and May 2025.

Main Results:

  • Four themes emerged: enhanced clinical confidence, workflow barriers, clinical/system implications, and conditions for sustained adoption.
  • HCPs reported increased professional empowerment and confidence due to MIPD's visualizations and retained decision authority.
  • Workflow barriers included documentation uncertainties, infrequent exposure hindering expertise, and operational challenges, particularly at night.

Conclusions:

  • Prioritizing electronic health record integration and automated dose calculation is essential for broader MIPD implementation.
  • Streamlining workflows and appointing local MIPD champions are crucial for reducing workload and errors.
  • These measures will support the sustainable use of MIPD in daily pediatric critical care practice.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
296
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
314
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
62
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
469